Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: A potential role for caspases

Histology and Histopathology

Volumn 24, Issue 8, 2009, Pages 1081-1086

  Rohn, Troy T ^a  

^a BOISE STATE UNIVERSITY   (United States)

Author keywords

Actin; ALS; Alzheimer's disease; Caspases; FTLD U; Hirano bodies; Pick bodies; Pick's disease; Review; Tau; TDP 43

Indexed keywords

CASPASE; DNA BINDING PROTEIN; PROTEIN TDP-43; TAR DNA BINDING PROTEIN;

BIOLOGICAL MODEL; CELL INCLUSION; CYTOSKELETON; DEGENERATIVE DISEASE; HUMAN; METABOLISM; REVIEW;

CASPASES; CYTOSKELETON; DNA-BINDING PROTEINS; HUMANS; INCLUSION BODIES; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES;

EID: 69149111339     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Amador-Ortiz C., Lin W. L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L. and Dickson D.W. (2007). TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61, 435-445.
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y. and Oda T. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys Res. Commun. 351, 602-611.
3. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E. and Baralle F.E. (2008). Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778-3785.
4. Buratti E. and Baralle F.E. (2001). Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337-36343.
5. Buratti E. and Baralle F.E. (2008). Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 13, 867-878.
6. Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M. and Baralle F.E. (2005). TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572-37584.
7. Cartier L., Galvez S. and Gajdusek D.C. (1985). Familial clustering of the ataxic form of Creutzfeldt-Jakob disease with Hirano bodies. J. Neurol. Neurosurg. Psychiatry 48, 234-238.
8. Checler F. and Vincent B. (2002). Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25, 616-620.
9. Dufty B.M., Warner L.R., Hou S.T., Jiang S.X., Gomez-Isla T., Leenhouts K.M., Oxford J.T., Feany M.B., Masliah E. and Rohn T.T. (2007). Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am. J. Pathol. 170, 1725-1738.
10. Fuentes-Prior P. and Salvesen G.S. (2004). The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384, 201-232.
11. Galloway P.G., Perry G. and Gambetti P. (1987). Hirano body filaments contain actin and actin-associated proteins. J. Neuropathol. Exp. Neurol. 46, 185-199.
12. Galloway P.G., Perry G., Kosik K.S. and Gambetti P. (1987). Hirano bodies contain tau protein. Brain Res. 403, 337-340.
13. Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., Lu M., Fu Y., Garcia-Sierra F., LaPointe N., Miller R., Berry R.W., Binder L.I. and Cryns V.L. (2003). Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci USA 100, 10032-10037.
14. Gibson P.H. and Tomlinson B.E. (1977). Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease. J. Neurol. Sci. 33, 199-206.
15. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., Nakano I., Oda T., Tsuchiya K. and Akiyama H. (2008). Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70.
16. Hirano A. (1994). Hirano bodies and related neuronal inclusions. Neuropathol. Appl. Neurobiol. 20, 3-11.
17. Hirano A., Dembitzer H.M., Kurland L.T. and Zimmerman H.M. (1968). The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and rod-like structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J. Neuropathol. Exp. Neurol. 27, 167-182.
18. Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., Clark C.M., Elman L.B., Miller B.L., Grossman M., McCluskey L.F., Trojanowski J.Q. and Lee V.M. (2008). Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182-194.
19. Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S. and Hasegawa M. (2008). Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 582, 2899-2904.
20. Johnson B.S., McCaffery J.M., Lindquist S. and Gitler A.D. (2008). A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 105, 6439-6444.
21. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N. and Rouleau G.A. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574.
22. Kwong L.K., Neumann M., Sampathu D.M., Lee V.M. and Trojanowski J.Q. (2007). TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 114, 63-70.
23. Liu C.W., Giasson B.I., Lewis K.A., Lee V.M., Demartino G.N. and Thomas P.J. (2005). A precipitating role for truncated alphasynuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson's disease. J. Biol. Chem. 280, 22670-22678.
24. Maciver S.K. and Harrington C.R. (1995). Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies. Neuroreport 6, 1985-1988.
25. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q. and Lee V.M. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
26. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F. and Gaynor R.B. (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584-3596.
27. Riedl S.J. and Shi Y. (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell. Biol. 5, 897-907.
28. Rissman R.A., Poon W.W., Blurton-Jones M., Oddo S., Torp R., Vitek M.P., LaFerla F.M., Rohn T.T. and Cotman C.W. (2004). Caspasecleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130.
29. Rohn T.T. (2008). Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Brain Res. 1228, 189-198.
30. Rohn T.T. and Kokoulina P. (2009). Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease. Int. J. Physiol. Pathophysiol. Pharmacol. 1, 24-31.
31. Rossiter J.P., Anderson L.L., Yang F. and Cole G.M. (2000). Caspasecleaved actin (fractin) immunolabelling of Hirano bodies. Neuropathol. Appl. Neurobiol. 26, 342-346.
32. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L. and Rademakers R. (2008). Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4, e1000193.
33. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G. and Shaw C.E. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
34. Wang I.F., Wu L.S., Chang H.Y. and Shen C.K. (2008). TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J. Neurochem. 105, 797-806.
35. Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q. and Lee V.M. (2008). Disturbance of nuclear and cytoplasmic TAR DNAbinding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309.
36. Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D. and Petrucelli L. (2007). Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534